Adaptive Biotechnologies Corp’s recent filing unveils that its Chief Scientific Officer ROBINS HARLAN S unloaded Company’s shares for reported $15282.0 on Mar 24 ’25. In the deal valued at $9.00 per share,1,698 shares were sold. As a result of this transaction, ROBINS HARLAN S now holds 1,279,524 shares worth roughly $9.38 million.
Then, Harlan Robins bought 1,698 shares, generating $14,705 in total proceeds.
Before that, GRIFFIN MICHELLE RENEE sold 36,291 shares. Adaptive Biotechnologies Corp shares valued at $260,932 were divested by the Director at a price of $7.19 per share. As a result of the transaction, GRIFFIN MICHELLE RENEE now holds 15,394 shares, worth roughly $0.11 million.
Goldman upgraded its Adaptive Biotechnologies Corp [ADPT] rating to a Buy from a a Neutral in a research note published recently. Scotiabank began covering ADPT with “Sector outperform” recommendation on January 05, 2023. Piper Sandler revised its rating on December 21, 2022. It rated ADPT as “an Overweight” which previously was an “a Neutral”.
Price Performance Review of ADPT
On Thursday, Adaptive Biotechnologies Corp [NASDAQ:ADPT] saw its stock fall -2.14% to $7.33. Over the last five days, the stock has lost -5.11%. Adaptive Biotechnologies Corp shares have risen nearly 22.27% since the year began. Nevertheless, the stocks have risen 166.55% over the past one year. While a 52-week high of $9.01 was reached on 03/24/25, a 52-week low of $2.28 was recorded on 01/02/25. SMA at 50 days reached $7.87, while 200 days put it at $5.95.
Levels Of Support And Resistance For ADPT Stock
The 24-hour chart illustrates a support level at 7.20, which if violated will result in even more drops to 7.08. On the upside, there is a resistance level at 7.50. A further resistance level may holdings at 7.68. The Relative Strength Index (RSI) on the 14-day chart is 43.95, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.16, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.15%. Stochastics %K at 43.67% indicates the stock is a holding.
How much short interest is there in Adaptive Biotechnologies Corp?
A steep rise in short interest was recorded in Adaptive Biotechnologies Corp stocks on 2025-03-31, growing by 1.46 million shares to a total of 10.12 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 8.66 million shares. There was a rise of 14.41%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 25, 2022 when Credit Suisse began covering the stock and recommended ‘”an Underperform”‘ rating along with a $8 price target.
